Search jobs 10-Feb-2021 Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe, the Commonwealth of Independent States and Japan
Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe, the Commonwealth of Independent States and Japan
New Patents to Support Global Partnering of Novel Bio-inspired Clot-dissolving Therapy
CAMBRIDGE, MA, February 10, 2021 / B3C newswire / Thrombolytic Science, LLC (TSI) today announced the granting of three new patents during the last 12 months. The invention relates to methods and compositions for safe and effective thrombolysis for ischemic stroke and heart attacks.
The two patents are part of a family of applications based on the international application No. PCT/US2015/058878. The European Patent Office granted Patent Number EP3215221 on February 26, 2020 and has been nationalized in 11 European countries. The Eurasian Patent Office granted Patent Number 03
(0)
DGAP-News: Thrombolytic Science, LLC / Key word(s): Patent/Research Update
Thrombolytic Science, LLC: Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe, the Commonwealth of Independent States and Japan
10.02.2021 / 12:00
Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe,
the Commonwealth of Independent States and Japan
New Patents to Support Global Partnering of Novel Bio-inspired Clot-dissolving Therapy
CAMBRIDGE, MA, February 10, 2021 Thrombolytic Science, LLC (TSI) today announced the granting of three new patents during the last 12 months. The invention relates to methods and compositions for safe and effective thrombolysis for ischemic stroke and heart attacks.
The two patents are part of a family of applications based on the international application No. PCT/US2015/058878. The European Patent Office granted Patent Number EP3215221 on February 26, 2020 and has been nationalized in 11 European countries. The Eurasian